Remove 2025 Remove Cannabis Remove Extraction Remove Patients
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Launch of Curaleaf International driven by the liberalisation of cannabis accelerating across Europe

Cannabis Law Report

billion by 2025 1. Projected growth of European cannabis market (Photo: Business Wire). It has been three years to the day since the UK Government’s landmark decision to legalise cannabis-based products for medicinal use, paving the way for further significant developments to the cannabis sector. billion by 2025 1.

article thumbnail

Curaleaf International Secures Complete GMP Certification of Second EU GMP Facility in Europe

Cannabis Law Report

Milestone for Medalchemy in Spain; facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and extracts. Accelerates export capacity to serve growing European and international medical cannabis markets. billion by 2025.

article thumbnail

Launch of Curaleaf International driven by the liberalisation of cannabis accelerating across Europe

Cannabis Law Report

billion by 2025 1. LONDON–(BUSINESS WIRE)–Curaleaf International (the “Company”) (formerly EMMAC Life Sciences Group), part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce its official rebrand to the European market. billion by 2025 1.

article thumbnail

A homegrown business: Medical cannabis firm Equinox set for a London IPO with an eye on ending Britain’s reliance on imports

Cannabis Law Report

UK currently imports 100% of its medical cannabis, which was legalised in 2018. Homegrown cannabis would be less ‘expensive, complex and time-consuming’. UK medical cannabis market to have addressable market of £7.5bn by 2028 .

article thumbnail

CORRECTING and REPLACING Heritage Cannabis Executes Term Sheet with Merida Capital Holdings to Support Entry into the Missouri Market in Relationship with 3Fifteen Primo Cannabis

Cannabis Law Report

The updated release reads: HERITAGE CANNABIS EXECUTES TERM SHEET WITH MERIDA CAPITAL HOLDINGS TO SUPPORT ENTRY INTO THE MISSOURI MARKET IN RELATIONSHIP WITH 3FIFTEEN PRIMO CANNABIS. Heritage Cannabis Holdings Corp. Total retail sales in Missouri are expected to grow to USD$650 million by 2025 per New Frontier Data.

Events 52